"Pseudomonas Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the genus PSEUDOMONAS.
| Descriptor ID |
D011552
|
| MeSH Number(s) |
C01.252.400.739
|
| Concept/Terms |
Pseudomonas Infections- Pseudomonas Infections
- Infections, Pseudomonas
- Infection, Pseudomonas
- Pseudomonas Infection
|
Below are MeSH descriptors whose meaning is more general than "Pseudomonas Infections".
Below are MeSH descriptors whose meaning is more specific than "Pseudomonas Infections".
This graph shows the total number of publications written about "Pseudomonas Infections" by people in this website by year, and whether "Pseudomonas Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 0 | 3 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 3 | 0 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 3 | 6 |
| 2006 | 0 | 1 | 1 |
| 2007 | 3 | 1 | 4 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 3 | 6 |
| 2010 | 4 | 2 | 6 |
| 2011 | 7 | 1 | 8 |
| 2012 | 2 | 0 | 2 |
| 2013 | 6 | 2 | 8 |
| 2015 | 1 | 1 | 2 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 2 | 4 |
| 2018 | 2 | 0 | 2 |
| 2019 | 3 | 2 | 5 |
| 2021 | 4 | 1 | 5 |
| 2022 | 2 | 0 | 2 |
| 2023 | 5 | 0 | 5 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pseudomonas Infections" by people in Profiles.
-
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin. Antimicrob Agents Chemother. 2024 Aug 07; 68(8):e0012724.
-
Impact of Pseudomonas aeruginosa on resource utilization and costs in patients with exacerbated non-cystic fibrosis bronchiectasis. J Med Econ. 2024 Jan-Dec; 27(1):671-677.
-
Development and validation of a rabbit model of Pseudomonas aeruginosa non-ventilated pneumonia for preclinical drug development. Front Cell Infect Microbiol. 2023; 13:1297281.
-
The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy. Antimicrob Agents Chemother. 2024 Jan 10; 68(1):e0100923.
-
Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Ann Am Thorac Soc. 2023 12; 20(12):1683-1693.
-
Interlaboratory comparison of Pseudomonas aeruginosa phage susceptibility testing. J Clin Microbiol. 2023 12 19; 61(12):e0061423.
-
Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics. Infect Immun. 2023 08 16; 91(8):e0006523.
-
In the Clear: Long-term pulmonary function benefits associated with Pseudomonas aeruginosa eradication. J Cyst Fibros. 2023 01; 22(1):7-8.
-
Green nail syndrome complicated by pseudomonal keratitis in a teenager with artificial nails. Pediatr Dermatol. 2023 Jan; 40(1):216-218.
-
Filamentous bacteriophage delays healing of Pseudomonas-infected wounds. Cell Rep Med. 2022 06 21; 3(6):100656.